// App-Quantinova.ai

: PROVE Study 506: Analysis of a Retrospective, Phase IV Study of Perampanel in Real-World Clinical Care of Patients Based on Study Site Participation in Previous Clinical Trials

Researchers

Presenter

  • Robert T Wechsler

Principal Investigators

  • James Wheless

  • Trevor Resnick

  • Alejandro Salah

  • Anna Patten

  • Manoj Malhotra

Medical Centers

  • Idaho Comprehensive Epilepsy Center, Boise, ID, USA

  • University of Tennessee Health Science Center/LeBonheur Children's Hospital, Memphis, TN

  • Department of Neurology, Nicklaus Children’s Hospital, Miami, FL, USA

  • Eisai Inc, Woodcliff Lake, NJ

  • Eisai Ltd., Hatfield, Hertfordshire, UK

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Perampanel

Outcome

  • N/A

Study Design

  • N/A

Phase

  • IV

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved